Literature DB >> 17442668

Expression and mechanism of spleen tyrosine kinase activation by angiotensin II and its implication in protein synthesis in rat vascular smooth muscle cells.

Fariborz A Yaghini1, Fang Li, Kafait U Malik.   

Abstract

Syk, a 72-kDa tyrosine kinase, is involved in development, differentiation, and signal transduction of hematopoietic and some non-hematopoietic cells. This study determined if Syk is expressed in vascular smooth muscle cells (VSMC) and contributes to angiotensin II (Ang II) signaling and protein synthesis. Syk was found in VSMC and was phosphorylated by Ang II through AT1 receptor. Ang II-induced Syk phosphorylation was inhibited by piceatannol and dominant negative but not wild type Syk mutant. Syk phosphorylation by Ang II was attenuated by cytosolic phospholipase A(2) (cPLA(2)) inhibitor pyrrolidine-1 and retrovirus carrying small interfering RNAs (shRNAs) of this enzyme. Arachidonic acid (AA) increased Syk phosphorylation, and AA- and Ang II-induced phosphorylation was diminished by inhibitors of AA metabolism (5,8,11,14-eicosatetraynoic acid) and lipoxygenase (LO; baicalein) but not cyclooxygenase (indomethacin). AA metabolites formed via LO, 5(S)-, 12(S)-, and 15(S)-hydroxyeicosatetraenoic acids, which activate p38 MAPK, increased Syk phosphorylation. p38 MAPK inhibitor SB202190, and dominant negative p38 MAPK mutant attenuated Ang II- and AA-induced Syk phosphorylation. Adenovirus dominant negative c-Src mutant abolished Ang II - and AA-induced Syk phosphorylation and SB202190, and dominant negative p38 MAPK mutant inhibited Ang II-induced c-Src phosphorylation. Syk dominant negative mutant but not epidermal growth factor receptor blocker AG1478 also inhibited Ang II-induced VSMC protein synthesis. These data suggest that Syk expressed in VSMC is activated by Ang II through p38 MAPK-activated c-Src subsequent to cytosolic phospholipase A(2) and generation of AA metabolites via LO, and it mediates Ang II-induced protein synthesis independent of epidermal growth factor receptor transactivation (Ang II --> cPLA(2) --> AA metabolites of LO --> p38 MAPK --> c-Src --> Syk --> protein synthesis).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442668     DOI: 10.1074/jbc.M610494200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

2.  Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.

Authors:  Cuneyt K Buharalioglu; Chi Young Song; Fariborz A Yaghini; Hafiz U B Ghafoor; Mustafa Motiwala; Tusita Adris; Anne M Estes; Kafait U Malik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-03       Impact factor: 4.733

3.  Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats.

Authors:  Brett L Jennings; Larry J Anderson; Anne M Estes; Xiao R Fang; Chi Young Song; William B Campbell; Kafait U Malik
Journal:  Am J Physiol Renal Physiol       Date:  2011-11-16

4.  Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.

Authors:  Brett L Jennings; Joseph A Moore; Ajeeth K Pingili; Anne M Estes; Xiao R Fang; Alie Kanu; Frank J Gonzalez; Kafait U Malik
Journal:  Am J Physiol Renal Physiol       Date:  2015-02-18

5.  Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation.

Authors:  Ye Cui; Wendy K Steagall; Anthony M Lamattina; Gustavo Pacheco-Rodriguez; Mario Stylianou; Pranav Kidambi; Benjamin Stump; Fernanda Golzarri; Ivan O Rosas; Carmen Priolo; Elizabeth P Henske; Joel Moss; Souheil El-Chemaly
Journal:  Cancer Res       Date:  2017-02-15       Impact factor: 12.701

6.  Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats.

Authors:  Brett L Jennings; David E Montanez; Michael E May; Anne M Estes; Xiao R Fang; Fariborz A Yaghini; Alie Kanu; Kafait U Malik
Journal:  Cardiovasc Drugs Ther       Date:  2014-04       Impact factor: 3.727

7.  Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.

Authors:  Zhongwen Xie; Ming C Gong; Wen Su; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2007-07-05       Impact factor: 5.157

8.  Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.

Authors:  Benon E Mugabe; Fariborz A Yaghini; Chi Young Song; Cuneyt K Buharalioglu; Christopher M Waters; Kafait U Malik
Journal:  J Pharmacol Exp Ther       Date:  2009-10-01       Impact factor: 4.030

9.  iPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling.

Authors:  Lindsay E Calderon; Shu Liu; Wen Su; Zhongwen Xie; Zhenheng Guo; Wanda Eberhard; Ming C Gong
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

10.  An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.

Authors:  Yingjie Han; Frank Y Ma; Julie Di Paolo; David J Nikolic-Paterson
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.